<bill session="115" type="h" number="2999" updated="2017-10-13T07:16:49Z">
  <state datetime="2017-06-22">REFERRED</state>
  <status>
    <introduced datetime="2017-06-22"/>
  </status>
  <introduced datetime="2017-06-22"/>
  <titles>
    <title type="short" as="introduced">Patients' Access to Treatments Act of 2017</title>
    <title type="short" as="introduced">Patients&#8217; Access to Treatments Act of 2017</title>
    <title type="official" as="introduced">To amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes.</title>
    <title type="display">Patients' Access to Treatments Act of 2017</title>
  </titles>
  <sponsor bioguide_id="M001180"/>
  <cosponsors>
    <cosponsor bioguide_id="A000371" joined="2017-07-12"/>
    <cosponsor bioguide_id="B001269" joined="2017-10-03"/>
    <cosponsor bioguide_id="B001278" joined="2017-06-23"/>
    <cosponsor bioguide_id="B001251" joined="2017-06-22"/>
    <cosponsor bioguide_id="C001084" joined="2017-06-22"/>
    <cosponsor bioguide_id="C001101" joined="2017-06-27"/>
    <cosponsor bioguide_id="C001078" joined="2017-06-22"/>
    <cosponsor bioguide_id="D000191" joined="2017-08-25"/>
    <cosponsor bioguide_id="E000288" joined="2017-06-27"/>
    <cosponsor bioguide_id="E000215" joined="2017-07-25"/>
    <cosponsor bioguide_id="K000210" joined="2017-10-03"/>
    <cosponsor bioguide_id="L000559" joined="2017-06-22"/>
    <cosponsor bioguide_id="M000087" joined="2017-06-27"/>
    <cosponsor bioguide_id="M000312" joined="2017-06-27"/>
    <cosponsor bioguide_id="N000179" joined="2017-06-22"/>
    <cosponsor bioguide_id="P000601" joined="2017-10-04"/>
    <cosponsor bioguide_id="P000597" joined="2017-06-23"/>
    <cosponsor bioguide_id="P000607" joined="2017-07-25"/>
    <cosponsor bioguide_id="R000602" joined="2017-10-12"/>
    <cosponsor bioguide_id="R000577" joined="2017-06-22"/>
    <cosponsor bioguide_id="S001150" joined="2017-06-29"/>
    <cosponsor bioguide_id="S000480" joined="2017-06-22"/>
    <cosponsor bioguide_id="S000522" joined="2017-06-22"/>
    <cosponsor bioguide_id="T000472" joined="2017-06-22"/>
  </cosponsors>
  <actions>
    <action datetime="2017-06-22">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-06-22" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2017-06-23">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Employee benefits and pensions"/>
    <term name="Health care costs and insurance"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2017-06-22T04:00:00Z" status="Introduced in House">Patients' Access to Treatments Act of 2017

This bill amends the Public Health Service Act to establish cost sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost sharing structure. Such health plans may not impose higher cost sharing requirements, including copayment and coinsurance, for specialty drugs than for other prescription drugs in a nonpreferred brand name drug tier. If a health plan's formulary contains more than one nonpreferred brand name drug tier, the tier with the lowest cost sharing applies.</summary>
  <committee-reports/>
</bill>
